| Terminated | A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer HR+ Metastatic Breast Cancer, Breast Cancer, Breast Cancer Metastatic | Phase 1 | 2019-11-21 |
| Terminated | Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/R Acute Myeloid Leukemia | Phase 3 | 2018-10-15 |
| Completed | A Study in Healthy Volunteers to Investigate How Much Test Medicine [14C]-Uproleselan is Taken up by the Body Healthy Subjects | Phase 1 | 2018-08-14 |
| Completed | A Study to Evaluate the Effect of Age on the Pharmacokinetics, Safety and Tolerability of IV Rivipansel. Healthy | Phase 1 | 2017-01-01 |
| Completed | A Study to Evaluate the Effect of IV Doses of Rivipansel in Subjects With Moderate Hepatic Impairment and in H Moderate Hepatic Impairment, Normal Hepatic Function | Phase 1 | 2016-09-01 |
| Completed | Placebo-Controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1359 in Healthy Volunteers Healthy | Phase 1 | 2016-08-01 |
| Terminated | Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombo Deep Venous Thrombosis | Phase 1 / Phase 2 | 2016-07-01 |
| Completed | A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subj Renal Impairment, Healthy | Phase 1 | 2016-06-01 |
| Completed | A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for Multiple Myeloma | Phase 1 | 2016-06-01 |
| Terminated | Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects Sickle Cell Anemia, Sickle Cell Disease, Sickle Cell Disorders | Phase 3 | 2015-12-16 |
| Completed | A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult S Healthy Volunteers | Phase 1 | 2015-11-01 |
| Completed | Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Rivipansel With rHuPH20 in He Healthy | Phase 1 | 2015-10-01 |
| Completed | Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | 2015-03-01 |
| Completed | Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects Healthy Volunteers | Phase 1 | 2014-10-01 |
| Completed | Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers Healthy Adult Subjects | Phase 1 | 2014-06-01 |
| Completed | A Study to Evaluate the Effect of IV Doses of GMI-1070 on Qtc Intervals in Healthy African-American Adult Subj Healthy | Phase 1 | 2013-08-01 |
| Completed | Study of GMI-1070 for the Treatment of Sickle Cell Pain Crisis Sickle Cell Disease, Vaso-occlusive Crisis, Pain Crisis | Phase 2 | 2010-05-01 |
| Completed | Study of Intravenous GMI-1070 in Adults With Sickle Cell Disease Sickle Cell Disease | Phase 1 / Phase 2 | 2009-05-01 |